Allan Mandelzys

Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada.

Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada.

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.

Bedrocan Cannabis Corp. produces, imports, and distributes pharmaceutical-grade medicinal cannabis to patients in Canada. Its products include Bedropuur, a tetrahydrocannibinol (THC) indica for THC extraction; Bedrocan, a sativa plant type cannabis; Bedica, an indica dominant strain of cannabis; and Bediol, Bedrolite, and Bedrobinol products, which are sativa dominant strains of cannabis. The company was founded by Murray Goldman and Marc Wayne on February 24, 2012 and is headquartered in Toronto, Canada.

8569975 Canada, Inc. provides other services. The private company is based in Dollard Des Ormeaux, Canada.

Searchlight Pharma, Inc. operates as a specialty healthcare company. It acquires and develops long life health care products. The company was founded in 2015 and is headquartered in Montreal, Canada.